✦ LIBER ✦

Measuring response to BCR-ABL inhibitors in chronic myeloid leukemia

✍ Scribed by Jerald P. Radich

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 176 KB
Volume: 118
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.26280

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Technical aspects and clinical applicati

Technical aspects and clinical applications of measuring BCR-ABL1 transcripts number in chronic myeloid leukemia

✍ Letizia Foroni; Gareth Gerrard; Emmanuel Nna; Jamshid Sorouri Khorashad; David S 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 230 KB

3′ BCR recombines with IGL locus in BCR-

3′ BCR recombines with IGL locus in BCR-ABL–positive Philadelphia-negative chronic myeloid leukemia

✍ Suzanne M. Benjes; Lynn J. Millow; Aaron R. Jeffs; Stephen J. Sowerby; Anthony E 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 235 KB

We have isolated the 3Ј BCR breakpoint junction of a complex BCR-ABL1 rearrangement found in leukemic cells with a cytogenetically normal karyotype, and the corresponding germline fragment that spanned the 3Ј BCR recombination site. Fluorescence in situ hybridization localized the 3Ј BCR recombinati

Complexity of BCR-ABL kinase domain muta

Complexity of BCR-ABL kinase domain mutations during the course of therapy with tyrosine kinase inhibitors in chronic myeloid leukemia

✍ Dushyant Verma; Carmen Fava; Hagop Kantarjian; Jorge Cortes 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

BCR/ABL fusion located on chromosome 9 i

BCR/ABL fusion located on chromosome 9 in chronic myeloid leukemia with a masked Ph chromosome

✍ Anwar N. Mohamed; F. Koppitch; M. Varterasian; C. Karanes; Kai-Ling Yao; F. H. S 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 394 KB

A reciprocal translocation, t( I022)(q2Z;q I I), resulting in a masked Ph chromosome was identified in a patient diagnosed with chronic myeloid leukemia (CML). Both homologs of chromosome 9 were of the normal pattern. Two signals for the ABL probe, both of them hybridized to chromosome 9, were demon

Stem cell transplantation for patients w

Stem cell transplantation for patients with chronic myeloid leukemia resistant to tyrosine kinase inhibitors with BCR-ABL kinase domain mutation T315I

✍ Nikolai Velev; Jorge Cortes; Richard Champlin; Dan Jones; Gabriela Rondon; Sergi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB 👁 1 views

Practical advice for determining the rol

Practical advice for determining the role of BCR-ABL mutations in guiding tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia

✍ Elias Jabbour; Susan Branford; Giuseppe Saglio; Dan Jones; Jorge E. Cortes; Hago 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 288 KB 👁 1 views

## Abstract Data demonstrating the superiority of nilotinib over imatinib in the frontline treatment of chronic myeloid leukemia (CML) and ongoing studies with dasatinib and bosutinib are rapidly changing the treatment landscape for CML. In this review, the authors discuss currently available thera